MedTrace Logo

AZD8683 Multiple Dose Study in Healthy Volunteers and Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT01584739 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2012-12-03

No results posted yet for this study

Summary

This study will investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple ascending inhaled doses of AZD8683 in Healthy volunteers and repeated inhalation of one dose level of AZD8683 in patients with chronic obstructive pulmonary disease given once daily.

Conditions

Interventions

DRUG

AZD8683

Multiple dose, oral inhalation (Healthy volunteers) Multiple dose, oral inhalation (COPD patients)

DRUG

Placebo

Multiple dose, oral inhalation (Healthy volunteers) Multiple dose, oral inhalation (COPD patients

Sponsors & Collaborators

Principal Investigators

  • Carin Jorup · AstraZeneca Research and Development SE-431 83 Molndal Sweden

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2012-11-30
Completion
2012-11-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01584739 on ClinicalTrials.gov